N-chlorosulfamate compositions having enhanced antimicrobial efficacy
AssigneeS.C. Johnson & Son, Inc.
InventorsWayne M. Rees, Debra S. Hilgers
Life of this patent
Estimating the term…
Loading patent…
AssigneeS.C. Johnson & Son, Inc.
InventorsWayne M. Rees, Debra S. Hilgers
Estimating the term…
The antimicrobial efficacy of N-chlorosulfamate solutions, namely buffered aqueous combinations of HClNSO3−(mono-N-chlorosulfamate) and Cl2NSO3 (di-N-chlorosulfamate), herein referred to as “stabilized hypochlorite”, can be markedly enhanced by the addition of certain organic dopants. The dopants themselves are select hypochlorite stabilizing agents, which are known to readily form stable organochloramides when reacted with “free” hypochlorite (HOCl or NaOCl). Highly effective antimicrobial enhancing dopants include 5,5-dialkyl hydantoins, arylsulfonamides, and succinimides. Examples of these include 5,5-dimethylhydantoin, benzenesulfonamide, and succinimide. Other, less effective dopants include glycolurils. Generally, the dopant is present in a minor mole fraction, relative to the molar amount of stabilized hypochlorite present in the enhanced antimicrobial solution.
An antimicrobial solution comprising:
A stabilized hypochlorite composition having enhanced microbial efficacy, and having a sulfamate to hypochlorite mole ratio of at least about 0.5:1.0, and a minimum mole ratio of dopant to hypochlorite of about 1:50,
An antimicrobial solution comprising:
Dependencies are inferred from the claim text.